Bioinformatic approaches to investigate mechanisms driving the non-T cell-inflamed tumor microenvironment

被引:0
|
作者
Luke, Jason [1 ]
机构
[1] Univ Chicago Med, Chicago, IL USA
来源
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
K10
引用
收藏
页数:1
相关论文
共 50 条
  • [21] DECREASED HOST PKC-DELTA IS ASSOCIATED WITH THE T CELL-INFLAMED TUMOR MICROENVIRONMENT AND IMPROVES ANTI-TUMOR IMMUNITY
    Cron, Kyle
    Sivan, Ayelet
    Aquino-Michaels, Keston
    Higgs, Emily
    Fessler, Jessica
    Lee, Seoho
    Sweis, Randy
    Gajewski, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A671 - A671
  • [22] Dendritic Cell Vaccination in Metastatic Melanoma Turns "Non-T Cell Inflamed" Into "T-Cell Inflamed" Tumors
    Bulgarelli, Jenny
    Tazzari, Marcella
    Granato, Anna Maria
    Ridolfi, Laura
    Maiocchi, Serena
    de Rosa, Francesco
    Petrini, Massimiliano
    Pancisi, Elena
    Gentili, Giorgia
    Vergani, Barbara
    Piccinini, Filippo
    Carbonaro, Antonella
    Leone, Biagio Eugenio
    Foschi, Giovanni
    Ancarani, Valentina
    Framarini, Massimo
    Guidoboni, Massimo
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [23] Conversion of non-T cell-inflamed triple-negative breast cancer by in situ immunomodulation of induced intratumoral cross-presenting dendritic cells
    Oba, Takaaki
    Keler, Tibor
    Marsh, Henry C.
    Abrams, Scott
    Ito, Fumito
    CANCER RESEARCH, 2020, 80 (04)
  • [24] Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
    Sweis, Randy F.
    Spranger, Stefani
    Bao, Riyue
    Paner, Gladell P.
    Stadler, Walter M.
    Steinberg, Gary
    Gajewski, Thomas F.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (07) : 563 - 568
  • [25] Anlotinib Induces a T Cell-Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
    Su, Yudong
    Luo, Bingying
    Lu, Yao
    Wang, Daowei
    Yan, Jie
    Zheng, Jian
    Xiao, Jun
    Wang, Yangyang
    Xue, Zhenyi
    Yin, Jie
    Chen, Peng
    Li, Long
    Zhao, Qiang
    CLINICAL CANCER RESEARCH, 2022, 28 (04) : 793 - 809
  • [26] The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
    Gajewski, Thomas F.
    SEMINARS IN ONCOLOGY, 2015, 42 (04) : 663 - 671
  • [27] Difference of Tumor Mutational Burden Is Associated with Distinct Immune Microenviroment in the T Cell-Inflamed Lung Adenocarcinoma
    Karasaki, T.
    Kitano, K.
    Nagayama, K.
    Nitadori, J.
    Sato, M.
    Anraku, M.
    Kakimi, K.
    Nakajima, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S423 - S423
  • [28] The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug development
    Olson, Daniel J.
    Luke, Jason J.
    IMMUNOTHERAPY, 2019, 11 (03) : 155 - 159
  • [29] IDENTIFICATION OF THE NON-T EFFECTOR CELL(S) MEDIATING TUMOR NEUTRALIZATION
    GOLDPOSEN, MH
    LEWIS, DA
    MILLER, GA
    HOLYOKE, ED
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1193 - 1193
  • [30] Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response
    Garris, Christopher S.
    Luke, Jason J.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 3901 - 3907